<SEC-DOCUMENT>0001104659-24-131663-index.html : 20241226 <SEC-HEADER>0001104659-24-131663.hdr.sgml : 20241226 <ACCEPTANCE-DATETIME>20241226141908 ACCESSION NUMBER: 0001104659-24-131663 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20241226 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-86901 FILM NUMBER: 241580508 BUSINESS ADDRESS: STREET 1: 11 APEX DRIVE, SUITE 300A STREET 2: PMB 2006 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 11 APEX DRIVE, SUITE 300A STREET 2: PMB 2006 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CVI Investments, Inc. CENTRAL INDEX KEY: 0001649553 ORGANIZATION NAME: IRS NUMBER: 981253664 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: P.O. BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 345-949-8080 MAIL ADDRESS: STREET 1: P.O. BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.I <SEQUENCE>2 <FILENAME>tm2431930d2_ex-1.htm <DESCRIPTION>EXHIBIT I <TEXT> Document 2 - file: tm2431930d2_ex-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.II <SEQUENCE>3 <FILENAME>tm2431930d2_ex-2.htm <DESCRIPTION>EXHIBIT II <TEXT> Document 3 - file: tm2431930d2_ex-2.htm
</DOCUMENT> </SEC-DOCUMENT>